Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival

Eur J Immunol. 2010 May;40(5):1369-74. doi: 10.1002/eji.200940046.

Abstract

Involvement of Treg in transplant tolerance has been demonstrated in multiple models. During the active process of graft rejection, these regulatory cells are themselves regulated and inactivated, a process termed counter-regulation. We hypothesize that ligation of the costimulatory molecule glucocorticoid-induced TNF receptor-related protein (GITR) on Treg inhibits their ability to promote graft survival, and by blocking GITR ligation graft survival can be prolonged. To this aim, we have designed a soluble GITR fusion protein (GITR-Fc), which binds GITR ligand and inhibits activation of GITR. Here, we show that GITR-Fc prolonged mouse skin graft survival, and this prolongation is dependent on Treg. In a full MHC-mismatched skin graft setting, GITR-Fc significantly improved graft survival when used in combination with MR1, anti-CD40L, while GITR-Fc alone did not demonstrate graft prolongation. These results demonstrate that disruption of binding of GITR with GITR ligand may be an important strategy in prolonging allograft survival.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adoptive Transfer
  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Antigen-Presenting Cells / drug effects
  • Antigen-Presenting Cells / immunology
  • Binding, Competitive
  • CD40 Ligand
  • Glucocorticoid-Induced TNFR-Related Protein
  • Graft Survival / drug effects*
  • Histocompatibility Antigens Class I
  • Humans
  • Immune Tolerance / drug effects
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Minor Histocompatibility Antigens
  • Receptors, Nerve Growth Factor / genetics
  • Receptors, Nerve Growth Factor / immunology*
  • Receptors, Tumor Necrosis Factor / genetics
  • Receptors, Tumor Necrosis Factor / immunology*
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / pharmacology
  • Recombinant Fusion Proteins / therapeutic use
  • Skin Transplantation / immunology*
  • T-Lymphocytes, Regulatory / immunology*
  • Transplantation, Homologous / immunology*
  • Tumor Necrosis Factor Inhibitors*
  • Tumor Necrosis Factors / immunology

Substances

  • Antibodies, Monoclonal
  • Glucocorticoid-Induced TNFR-Related Protein
  • Histocompatibility Antigens Class I
  • Immunosuppressive Agents
  • Minor Histocompatibility Antigens
  • Mr1 protein, mouse
  • Receptors, Nerve Growth Factor
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Tnfrsf18 protein, mouse
  • Tnfsf18 protein, mouse
  • Tumor Necrosis Factor Inhibitors
  • Tumor Necrosis Factors
  • CD40 Ligand